Related Experiment Videos
Cholestasis in HIV-infected patients
1Center for Liver Diseases, University of Chicago Hospitals, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA. hte@uchicago.edu
Clinics in Liver Disease
|April 6, 2004
Summary
Cholestasis in HIV patients has multiple causes, including medications and infections. Early diagnosis and treatment are crucial for better outcomes in the highly active antiretroviral therapy (HAART) era.
Area of Science:
- Hepatology
- Infectious Diseases
- HIV Medicine
Background:
- Cholestasis is a common complication in Human Immunodeficiency Virus (HIV)-infected individuals.
- Causes include medications like highly active antiretroviral therapy (HAART) and opportunistic infections.
- Less frequent causes involve HIV-related cancers and biliary tract issues.
Purpose of the Study:
- To review the causes and management of cholestasis in HIV patients.
- To highlight the impact of the HAART era on patient outcomes.
Main Methods:
- Literature review of cholestasis in HIV-infected patients.
- Analysis of pre-HAART and HAART era outcomes.
Main Results:
- Drug-induced cholestasis (HAART, antimicrobials) and infections are primary causes.
- Patient outcomes were historically linked to HIV stage and comorbidities.
- The HAART era offers improved prognosis with timely interventions.
Conclusions:
- Prompt recognition and targeted treatment of cholestasis are vital for HIV patients.
- Management strategies have evolved, improving outcomes in the HAART era.